Thus, apart from the increase in LF observed in the present study, which could sensitize PDAC cells to checkpoint inhibitors, an increase in radixin could also possibly aid in increasing immunotherapy by immune checkpoint inhibitors of PD-L1 in pancreatic cancer cells. This evidence concerns the gene CD274 and pancreatic neoplasm.